|Free Dividend Report|
|Stock Splits Calendar|
|ACST Stock Split History|
|Preferred Stock Newsletter|
|Top Option Ideas|
|Stock Message Boards|
Acasti Pharma (ACST) has 2 splits in our ACST split history database. The first split for ACST took place on December 12, 2003. This was a 1 for 89 reverse split, meaning for each 89 shares of ACST owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 11.2359550561798 share position following the split. ACST's second split took place on October 15, 2015. This was a 1 for 10 reverse split, meaning for each 10 shares of ACST owned pre-split, the shareholder now owned 1 share. For example, a 11.2359550561798 share position pre-split, became a 1.12359550561798 share position following the split.
When a company such as Acasti Pharma conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.
Looking at the ACST split history from start to finish, an original position size of 1000 shares would have turned into 1.12359550561798 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Acasti Pharma shares, starting with a $10,000 purchase of ACST, presented on a split-history-adjusted basis factoring in the complete ACST split history.
Growth of $10,000.00
Without Dividends Reinvested
|Average Annual Total Return:||-33.18%|
|About Acasti Pharma|
|Acasti Pharma is a biopharmaceutical company focused on the research, development and commercialization of prescription drugs using omega-3 fatty acids (OM3) delivered both as free fatty acids and bound-to-phospholipid esters derived from krill oil. Co.'s primary product candidate is CaPre, an OM3 phospholipid therapeutic, which it is developing for the treatment of severe hypertriglyceridemia, a condition characterized by high or severe levels of triglycerides in the bloodstream. According to our ACST split history records, Acasti Pharma has had 2 splits.|
|ACST Split History Table|
|12/12/2003||1 for 89|
|10/15/2015||1 for 10|
|Healthcare Stock Splits|
|ACST is categorized under the Healthcare sector; below are some other companies in the same sector that also have a history of stock splits:
Also explore: ACST shares outstanding history